Christos Nicholoudis - Aug 17, 2023 Form 4 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role
Director
Signature
/s/ Michelle Yanez, Attorney-in-Fact for Christos Nicholoudis
Stock symbol
MIRA
Transactions as of
Aug 17, 2023
Transactions value $
$0
Form type
4
Date filed
8/21/2023, 06:00 PM
Previous filing
Aug 2, 2023
Next filing
Feb 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRA Stock Options Award $0 +10K $0.00 10K Aug 17, 2023 Common Stock 10K $6.50 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 17, 2023.
F2 The stock options were issued to the Reporting Person on August 17,2023, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. The award vested in full on August 17,2023.